Who founded Cytek Biosciences?

Cytek Biosciences was founded by Wenbin Jiang, Ph.D., Wenbin Jiang.

Who are Cytek Biosciences's investors?

Cytek Biosciences's investors include 3E Bioventures Capital, F-Prime Capital, Northern Light Venture Capital, RA Capital.

How much funding has Cytek Biosciences raised?

Cytek Biosciences has disclosed $120M raised across 1 round.

Where is Cytek Biosciences headquartered?

Cytek Biosciences is headquartered in Bellevue, US.

Cytek Biosciences

NASDAQ: CTKBUnicorn · $2.2B

Bellevue, US · Delaware corporation · 454 employees on LinkedIn · 4 known investors

Find your way into Cytek Biosciences

68 people in our graph share verified history with the Cytek Biosciences team — schools, employers, funds. One of them is your warm intro.

Andrew Ogawaunlockedknows Wenbin Jiang · together at UC Santa Barbara (overlapped)

×8knows the team · via UC Santa Barbara

×2knows the team · via Cytek Biosciences

knows the team · via UC Santa Barbara Foundation

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.

Biotech Deep Tech Hardware Healthtech Medical Devices

Founders & leadership

Wenbin Jiang, Ph.D.CEO and Chairman of the Board

Wenbin Jiang inCo-founder · CEO and Chairman of the BoardHe brings expertise in semiconductor laser and photodiode technologies, and has background in R&D management, technical marketing, and IP strategy.

Ming Yan, Ph.D.Chief Technology Officer

Ming YaninCTO

Jiecheng ZhangNamed on SEC filing

Allen PoirsonNamed on SEC filing

Jack BallNamed on SEC filing

Board

Andrew LevinBoard directorPartner at RA Capital

Feng DengBoard directorGeneral Partner at Northern Light Venture Capital

Investors · 4

3E Bioventures CapitalPalo Alto

F-Prime CapitalCambridge · $3M – $10M

Northern Light Venture CapitalMenlo Park · $1.3M – $100M

RA CapitalreportedBoston

Reported raises · per SEC filings

Form D private placements

$120M disclosed across 1 round · 2020

▶$120MraisedNov 2020 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ming YanExecutive Officer, Director
Jiecheng ZhangDirector
Allen PoirsonDirector
Andrew LevinDirector
Feng DengDirector
Jack BallDirector
Wenbin JiangExecutive Officer, Director

Offering amount: $120M
Amount sold: $120M
Minimum investment: $1
First sale: Oct 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events

$2.2Bvaluation at IPOJul 2021 · $17.00/share · 424B4

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Competitors · 2

by search overlap

Abcam354 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.

Fluorofinder205 shared keywordsFluoroFinder offers an AI-enabled platform for designing flow cytometry and fluorescent microscopy experiments, analyzing marker and fluorophore combinations across more than 3 million products from 78+ suppliers. It serves researchers, labs, and core facilities to select compatible reagents and plan experiments within their lab's configuration.

Companies competing with Cytek Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cytek Biosciences do?: Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.
Who founded Cytek Biosciences?: Cytek Biosciences was founded by Wenbin Jiang, Ph.D., Wenbin Jiang.
Who are Cytek Biosciences's investors?: Cytek Biosciences's investors include 3E Bioventures Capital, F-Prime Capital, Northern Light Venture Capital, RA Capital.
How much funding has Cytek Biosciences raised?: Cytek Biosciences has disclosed $120M raised across 1 round.
Where is Cytek Biosciences headquartered?: Cytek Biosciences is headquartered in Bellevue, US.